Login to Your Account

Genentech, Elan Deals Limiting?

Biogen Idec Officially Hunts Buyer; Icahn, Pharma Hover

By Randall Osborne

Tuesday, October 16, 2007
Biogen Idec Inc.'s confirmation of months-long buzz that the company is talking with potential buyers boosted the stock and started onlookers speculating about advantages, drawbacks and hurdles - as well as the timing of a potential deal, given worries that still linger over Tysabri, and given Biogen's possibly value-stimulating pipeline news in the year ahead. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription